AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,212.00p
   
  • Change Today:
    -204.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,725.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.61m
  • Volume: 145,165
  • Market Cap: £173,854m
  • RiskGrade: 123

Latest ShareCast News

AstraZeneca makes regulatory progress with Imfinzi, Calquence

By Josh White

Date: Monday 31 Mar 2025

AstraZeneca spending $2.5bn on new R&D centre, biotech deals in China

By Benjamin Chiou

Date: Friday 21 Mar 2025

(Sharecast News) - Pharma giant AstraZeneca announced on Friday that it is investing $2.5bn in a new global R&D centre in China, along with major research and manufacturing agreements with three of the country's biotech firms.

AstraZeneca buys biotech firm Esobiotec for up to $1bn

By Benjamin Chiou

Date: Monday 17 Mar 2025

(Sharecast News) - AstraZeneca announced on Monday that it is spending up to $1bn to acquire Belgian biotech firm EsoBiotec, which it says has the potential to "transform" cell therapy.

AstraZeneca hails trial results for imfinzi on g... 07-Mar-2025 ShareCast
AstraZeneca's Imfinzi gets recommended for fresh... 03-Mar-2025 ShareCast
AstraZeneca's camizestrant shows promise in brea... 26-Feb-2025 ShareCast
London close: Stocks slip as US jobless claims r... 20-Feb-2025 ShareCast
UBS ups rating on AstraZeneca to 'buy' 13-Feb-2025 ShareCast
Morgan Stanley sees huge upside at AstraZeneca 12-Feb-2025 ShareCast
Revenues, profits surge at AstraZeneca 06-Feb-2025 ShareCast
AstraZeneca's Imfinzi set for go-ahead by EU to ... 03-Feb-2025 ShareCast
AstraZeneca's Enhertu gets new US approval 28-Jan-2025 ShareCast
AstraZeneca gets first US approval for cancer tr... 20-Jan-2025 ShareCast
AstraZeneca's rare cancer drug Calquence gets US... 17-Jan-2025 ShareCast
London close: Stocks mixed in quiet post-Christm... 27-Dec-2024 ShareCast
AstraZeneca pulls EU application for cancer drug 24-Dec-2024 ShareCast
AstraZeneca lung cancer drug Tagrisso approved b... 23-Dec-2024 ShareCast
AstraZeneca cancer drug secures US approval 05-Dec-2024 ShareCast
AstraZeneca appoints Iskra Reic as vice-presiden... 04-Dec-2024 ShareCast
AstraZeneca reports positive results from prosta... 25-Nov-2024 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,212.00p
Change Today -204.00p
% Change -1.79 %
52 Week High 13,276.00
52 Week Low 9,725.00
Volume 145,165
Shares Issued 1,550.61m
Market Cap £173,854m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.34% below the market average93.34% below the market average93.34% below the market average93.34% below the market average93.34% below the market average
87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average
Price Trend
41.51% above the market average41.51% above the market average41.51% above the market average41.51% above the market average41.51% above the market average
51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average
Income
65.81% below the market average65.81% below the market average65.81% below the market average65.81% below the market average65.81% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Growth
85.34% above the market average85.34% above the market average85.34% above the market average85.34% above the market average85.34% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 15
Neutral 4
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 31-Mar-2025

Time Volume / Share Price
12:09 43 @ 11,212.00p
12:08 11 @ 11,214.67p
12:08 0 @ 11,218.00p
12:08 0 @ 11,218.00p
12:08 0 @ 11,218.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page